134 related articles for article (PubMed ID: 37593923)
1. Heterogeneous splicing patterns resulting from KIF5A variants associated with amyotrophic lateral sclerosis.
Pino MG; Rich KA; Hall NJ; Jones ML; Fox A; Musier-Forsyth K; Kolb SJ
Hum Mol Genet; 2023 Nov; 32(22):3166-3180. PubMed ID: 37593923
[TBL] [Abstract][Full Text] [Related]
2. Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variant.
Rich KA; Pino MG; Yalvac ME; Fox A; Harris H; Balch MHH; Arnold WD; Kolb SJ
Neurobiol Dis; 2023 Jun; 182():106148. PubMed ID: 37164288
[TBL] [Abstract][Full Text] [Related]
3. ALS-Associated KIF5A Mutation Causes Locomotor Deficits Associated with Cytoplasmic Inclusions, Alterations of Neuromuscular Junctions, and Motor Neuron Loss.
Soustelle L; Aimond F; López-Andrés C; Brugioti V; Raoul C; Layalle S
J Neurosci; 2023 Nov; 43(47):8058-8072. PubMed ID: 37748861
[TBL] [Abstract][Full Text] [Related]
4. Hot-spot KIF5A mutations cause familial ALS.
Brenner D; Yilmaz R; Müller K; Grehl T; Petri S; Meyer T; Grosskreutz J; Weydt P; Ruf W; Neuwirth C; Weber M; Pinto S; Claeys KG; Schrank B; Jordan B; Knehr A; Günther K; Hübers A; Zeller D; Kubisch C; Jablonka S; Sendtner M; Klopstock T; de Carvalho M; Sperfeld A; Borck G; Volk AE; Dorst J; Weis J; Otto M; Schuster J; Del Tredici K; Braak H; Danzer KM; Freischmidt A; Meitinger T; Strom TM; Ludolph AC; Andersen PM; Weishaupt JH;
Brain; 2018 Mar; 141(3):688-697. PubMed ID: 29342275
[TBL] [Abstract][Full Text] [Related]
5. An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity.
Nakano J; Chiba K; Niwa S
Genes Cells; 2022 Jun; 27(6):421-435. PubMed ID: 35430760
[TBL] [Abstract][Full Text] [Related]
6. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.
Baron DM; Fenton AR; Saez-Atienzar S; Giampetruzzi A; Sreeram A; Shankaracharya ; Keagle PJ; Doocy VR; Smith NJ; Danielson EW; Andresano M; McCormack MC; Garcia J; Bercier V; Van Den Bosch L; Brent JR; Fallini C; Traynor BJ; Holzbaur ELF; Landers JE
Cell Rep; 2022 Apr; 39(1):110598. PubMed ID: 35385738
[TBL] [Abstract][Full Text] [Related]
7. Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis.
Nakamura R; Tohnai G; Atsuta N; Nakatochi M; Hayashi N; Watanabe H; Yokoi D; Watanabe H; Katsuno M; Izumi Y; Taniguchi A; Kanai K; Morita M; Kano O; Kuwabara S; Oda M; Abe K; Aoki M; Aiba I; Okamoto K; Mizoguchi K; Hattori N; Nakashima K; Kaji R; Sobue G;
Neurobiol Aging; 2021 Jan; 97():147.e11-147.e17. PubMed ID: 32888732
[TBL] [Abstract][Full Text] [Related]
8. ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function.
Pant DC; Parameswaran J; Rao L; Loss I; Chilukuri G; Parlato R; Shi L; Glass JD; Bassell GJ; Koch P; Yilmaz R; Weishaupt JH; Gennerich A; Jiang J
EMBO Rep; 2022 Aug; 23(8):e54234. PubMed ID: 35735139
[TBL] [Abstract][Full Text] [Related]
9. Splice-site mutations in KIF5A in the Japanese case series of amyotrophic lateral sclerosis.
Naruse H; Ishiura H; Mitsui J; Takahashi Y; Matsukawa T; Sakuishi K; Nakamagoe K; Miyake Z; Tamaoka A; Goto J; Yoshimura J; Doi K; Morishita S; Toda T; Tsuji S
Neurogenetics; 2021 Mar; 22(1):11-17. PubMed ID: 32815063
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of KIF5A in Chinese amyotrophic lateral sclerosis patients.
Zhang K; Liu Q; Shen D; Tai H; Liu S; Wang Z; Shi J; Fu H; Wu S; Ding Q; Hu Y; Wu Y; Li X; Guan Y; Liu M; Cui L; Zhang X
Neurobiol Aging; 2019 Jan; 73():229.e1-229.e4. PubMed ID: 30301576
[TBL] [Abstract][Full Text] [Related]
11. High-throughput analysis revealed mutations' diverging effects on
Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya ; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; ; Mora G; Calvo A; Mazzini L; Riva N; Mandrioli J; Caponnetto C; Battistini S; Volanti P; La Bella V; Conforti FL; Borghero G; Messina S; Simone IL; Trojsi F; Salvi F; Logullo FO; D'Alfonso S; Corrado L; Capasso M; Ferrucci L; ; Moreno CAM; Kamalakaran S; Goldstein DB; ; Gitler AD; Harris T; Myers RM; ; Phatnani H; Musunuri RL; Evani US; Abhyankar A; Zody MC; ; Kaye J; Finkbeiner S; Wyman SK; LeNail A; Lima L; Fraenkel E; Svendsen CN; Thompson LM; Van Eyk JE; Berry JD; Miller TM; Kolb SJ; Cudkowicz M; Baxi E; ; Benatar M; Taylor JP; Rampersaud E; Wu G; Wuu J; ; Lauria G; Verde F; Fogh I; Tiloca C; Comi GP; Sorarù G; Cereda C; ; Corcia P; Laaksovirta H; Myllykangas L; Jansson L; Valori M; Ealing J; Hamdalla H; Rollinson S; Pickering-Brown S; Orrell RW; Sidle KC; Malaspina A; Hardy J; Singleton AB; Johnson JO; Arepalli S; Sapp PC; McKenna-Yasek D; Polak M; Asress S; Al-Sarraj S; King A; Troakes C; Vance C; de Belleroche J; Baas F; Ten Asbroek ALMA; Muñoz-Blanco JL; Hernandez DG; Ding J; Gibbs JR; Scholz SW; Floeter MK; Campbell RH; Landi F; Bowser R; Pulst SM; Ravits JM; MacGowan DJL; Kirby J; Pioro EP; Pamphlett R; Broach J; Gerhard G; Dunckley TL; Brady CB; Kowall NW; Troncoso JC; Le Ber I; Mouzat K; Lumbroso S; Heiman-Patterson TD; Kamel F; Van Den Bosch L; Baloh RH; Strom TM; Meitinger T; Shatunov A; Van Eijk KR; de Carvalho M; Kooyman M; Middelkoop B; Moisse M; McLaughlin RL; Van Es MA; Weber M; Boylan KB; Van Blitterswijk M; Rademakers R; Morrison KE; Basak AN; Mora JS; Drory VE; Shaw PJ; Turner MR; Talbot K; Hardiman O; Williams KL; Fifita JA; Nicholson GA; Blair IP; Rouleau GA; Esteban-Pérez J; García-Redondo A; Al-Chalabi A; ; Rogaeva E; Zinman L; Ostrow LW; Maragakis NJ; Rothstein JD; Simmons Z; Cooper-Knock J; Brice A; Goutman SA; Feldman EL; Gibson SB; Taroni F; Ratti A; Gellera C; Van Damme P; Robberecht W; Fratta P; Sabatelli M; Lunetta C; Ludolph AC; Andersen PM; Weishaupt JH; Camu W; Trojanowski JQ; Van Deerlin VM; Brown RH; van den Berg LH; Veldink JH; Harms MB; Glass JD; Stone DJ; Tienari P; Silani V; Chiò A; Shaw CE; Traynor BJ; Landers JE
Neuron; 2018 Mar; 97(6):1267-1288. PubMed ID: 29566793
[TBL] [Abstract][Full Text] [Related]
13. Computational study of the motor neuron protein KIF5A to identify nsSNPs, bioactive compounds, and its key regulators.
Kumar R; Madhavan T; Ponnusamy K; Sohn H; Haider S
Front Genet; 2023; 14():1282234. PubMed ID: 38028604
[No Abstract] [Full Text] [Related]
14. Genotype-phenotype correlations of
de Boer EMJ; van Rheenen W; Goedee HS; Kamsteeg EJ; Brilstra EH; Veldink JH; van Den Berg LH; van Es MA
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):561-570. PubMed ID: 33829936
[TBL] [Abstract][Full Text] [Related]
15. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome Sequencing Identified a Novel Mutation in the N-Terminal Domain of
Wang H; Guan L; Ma X; Wang Y; Wang J; Zhang P; Deng M
Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927616
[TBL] [Abstract][Full Text] [Related]
17. Lab resource: Single cell line generation and characterization of a human-derived induced pluripotent stem cell line (IGIBi005-A) from a patient with spastic paraplegia/ataxia/ALS phenotype due to the mutation of the gene Kinesin Family Member 5A (KIF5A).
Ahmad I; Goel D; Ghosh A; Kapoor H; Kumar D; Srivastava AK; Faruq M
Stem Cell Res; 2022 Oct; 64():102904. PubMed ID: 36055117
[TBL] [Abstract][Full Text] [Related]
18. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
Exline CM; Feng Z; Stoltzfus CM
J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
[TBL] [Abstract][Full Text] [Related]
19. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.
Fratta P; Sivakumar P; Humphrey J; Lo K; Ricketts T; Oliveira H; Brito-Armas JM; Kalmar B; Ule A; Yu Y; Birsa N; Bodo C; Collins T; Conicella AE; Mejia Maza A; Marrero-Gagliardi A; Stewart M; Mianne J; Corrochano S; Emmett W; Codner G; Groves M; Fukumura R; Gondo Y; Lythgoe M; Pauws E; Peskett E; Stanier P; Teboul L; Hallegger M; Calvo A; Chiò A; Isaacs AM; Fawzi NL; Wang E; Housman DE; Baralle F; Greensmith L; Buratti E; Plagnol V; Fisher EM; Acevedo-Arozena A
EMBO J; 2018 Jun; 37(11):. PubMed ID: 29764981
[TBL] [Abstract][Full Text] [Related]
20. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation.
Zhou Y; Liu S; Liu G; Oztürk A; Hicks GG
PLoS Genet; 2013 Oct; 9(10):e1003895. PubMed ID: 24204307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
